Abstract
Background:
Styrene (ST) is widely used as an organic solvent in many industrial settings. Increasing evidence indicated that ST induced toxicity in human and animals. Occupational exposure to ST can result in multiple-organ toxicity.Objectives:
The aim of the present study was to investigate the preventive effect of vitamin C (Vit C) on ST- induced toxicity in rat liver and kidney.Materials and Methods:
Adult male rats were pretreated with 300 mg/kg Vit C intraperitoneally. Control rats received vehicle only (distilled water, D H2O). Thirty minutes later, animals were given different doses (0, 200, 400, or 600 mg/kg) of ST. Twenty-four hours later, animals were killed and their blood samples were processed for determination of biochemical parameters. Liver damage was estimated by measuring serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) activity. nephrotoxicity was evaluated by measuring blood urea nitrogen (BUN) and creatinine (CR) concentrations. Liver and kidney tissues were removed, fixed and processed for light microscopy.Results:
Styrene induced a dose-dependent elevation in the AST, ALT, ALP, BUN, and CR levels when compared to those of the control animals. The liver and kidney tissues were intact in control rats. Moreover, ST provoked a dose-dependent injury in the liver and kidney tissues. Vitamin C significantly decreased all biochemical parameters and protected liver and kidney cells against ST-induced toxicity.Conclusions:
The results of this study showed that Vit C has potential to protect rat liver and kidney tissues against styrene toxicity.Keywords
1. Background
Styrene (ST) is a widely used organic solvent. This chemical is used in the production of many products including polymers which are incorporated into products such as plastic, rubber, fiberglass and food containers. Styrene exposure has been associated with numerous health effects in human and experimental animals. Occupational exposure to this agent can cause fatigue, memory lost, and liver plus kidney damage (1, 2). Moreover, ST may be absorbed into blood stream by all routes of administrations (2-6). Hepatotoxicity and nephrotoxicity of ST are the most common concerns among workers exposed to this chemical. The liver plays a major role in the biotransformation of the xenobiotic. Numerous studies have identified ST- induced hepatotoxicity in humans (2, 7-9). Kidney damage was also noted in workers occupationally exposed to ST (10, 11). The metabolites of ST observed in the urine of rats and humans (12-14). This has led to demand for to study laboratory animals to be used in the early diagnosis and prevention of occupational diseases.
A large body of evidence indicated that ST is metabolized by cytochrome p450 to reactive toxic intermediate mainly Styrene Oxide (SO). Covalent binding of SO to essential macromolecules produces cell injury (15, 16). Styrene metabolite decreased plasma GSH levels in mice (17). ST induced cell injury (18). These authors found that Glutathione (GSH), N-Acetylcysteine (NAC) protected liver against ST-induced toxicity in experimental animals (18). Vitamin C (Vit C) plays an important role as an antioxidant to protect cells against free radical produced injury. This chemical has ability to scavenge free radicals and also protecting cell membrane by regenerating the antioxidant (19, 20). Investigation regarding the effect of Vit C on ST-induced toxicity may be useful for better understanding of the clinical pictures following ST exposures in humans.
2. Objectives
For a better understanding of ST toxicity, this study was undertaken to determine the preventive effect of Vit C on styrene-induced toxicity in rat liver and kidney.
3. Materials and Methods
Adult male wistar rats (250-300 g) were housed in groups of 3 in clear polypropylene cages in a light cycle (12 h light and 12 h dark) and temperature-controlled room. The animals were allowed food and tap water ad libitum. The animals were pretreated with an intraperitoneal injection of 300 mg/kg Vit C (21). Control rats received vehicle only (distilled water, D H2O). After 30 minutes, animals were given different doses (0, 200, 400, or 600 mg/kg, ip) of ST (15). After 24 hours, all animals were killed with over dose of sodium pentobarbital. The animals' blood sample was collected for determination of biochemical parameters. Liver damage was estimated by measuring serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) activity. Nephrotoxicity was evaluated by measuring blood urea nitrogen (BUN) and creatinine (CR) levels. The liver and kidney tissues were removed, fixed and processed for light microscopy. The tissue samples were fixed in 10% buffered formalin for 24 hours, routinely processed and paraffin embedded. Five histological sections each at least 15 µm apart were taken from each tissue block and stained with hematoxylin and eosin (H and E). The protocol was approved by the ethics committee of the Ahvaz Jundishapur University of Medical Sciences.
Biochemical data were expressed as mean ± standard error. The data were analyzed using analysis of variance (ANOVA), a completely randomized design, and treatment differences were identified using the Newman-Keuls method. P value < 0.05 was considered as the criterion for significance. Five animals were used for each treatment group.
4. Results
A dose-related increase in biochemical parameters was observed in ST-treated when compared to control animals. Vitamin C had no effect on blood biochemical parameters. However, the AST, ALT, and ALP levels were significantly (P < 0.05) decreased in rats received various doses of ST and Vit C when compared to those which received ST only at the same dose (Table 1).
| Parameters | Treatment | Dose, mg/kg | |||
|---|---|---|---|---|---|
| 0 | 200 | 400 | 600 | ||
| AST | |||||
| ST | 30.9 ± 1.67 | 71.1 ± 3.32 c | 77.8 ± 2.94 c | 86.6 ± 2.56 c | |
| VC + ST | 31.1 ± 1.67 | 59.4 ± 4.73 | 67.8 ± 1.85 | 78.2 ± 3.31 | |
| ALT | |||||
| ST | 29.4 ± 4.97 | 37.4 ± 4.82 | 39.2 ± 3.72 c | 47.6 ± 3.89 c | |
| VC + ST | 28.3 ± 4.93 | 36.4 ± 4.39 | 30.8 ± 2.38 | 38.4 ± 2.89 | |
| ALP | |||||
| ST | 97.3 ± 4.54 | 107.8 ± 2.14 c | 122.2 ± 3.75 c | 147.4 ± 3.67 c | |
| VC + ST | 96.2 ± 4.2 | 99.8 ± 2.28 | 102.2 ± 3.75 | 124.3 ± 4.79 | |
Administration of vehicle alone did not produce detectable injury in rat liver (Figure 1). In control rats (vehicle-treated animals) liver cells were intact. There was no detectable injury in hepatocytes (Figure 1). However, ST induced injury in the liver. The extent of injury appeared to be a dose- and time-related manner. However, the most remarkable histopathological alterations were noted in rats treated with 600 mg/kg ST. The liver cells were intensively swollen. The vessels of portal space and centrilobular vein being distended and congested with hemolyzed material. The hepatocytes were enlarged and granular with many vacuoles. The nuclei were appeared to be larger. Hydropic degeneration was obvious (Figure 2). Vitamin C had no effect on liver tissue and there was no obvious injury. However, this agent protected hepatocytes against ST-produced cytotoxicity (Figure 3).
Light Micrograph of Liver of Control Rat Treated With Vehicle (Normal Saline)
Light Micrograph of Rat Liver Treated With 600 mg/kg Styrene
Light Micrograph of Rat Liver Pretreated With 300 mg/kg Vitamin C and Received 600 mg/kg ST
A dose-related increase in BUN and CR concentrations was observed in ST-treated animals compared to those in the control group. Elevation of renal biochemical parameters was predominant in rats treated with 600 mg/kg ST (Table 2).
Vitamin C had no effect on BUN and CR when compared to control animals. However, pretreated animals with this agent markedly reduced the level of biochemical parameters when compared to ST-treated rats (Table 2). Administration of vehicle alone did not produce detectable injury in rat kidney (Figure 4). However, a dose-related injury in the ST-treated rats was noted. Light microscopy revealed that renal tubular cells were swollen, had loss of staining capacity, and nuclei appeared to be dilated, presence of blood clot was noted in the ST-treated rats (Figure 5). Similarly, Vit C had no effect on kidney cells. However, the extent of ST-induced injury was decreased in Vit C pretreated rats when compared to those treated with ST only (Figure 6).
Light Micrograph of Rat Kidney Treated With Vehicle (Normal Saline)
Light Micrograph of Rat Kidney Treated With 600 mg/kg Styrene
Light Micrograph of Rat Liver Pretreated With 300 mg/kg Vitamin C and Received 600 mg/kg Styrene
5. Discussion
The liver is the main organ for xenobiotic biotransformation. Human hepatotoxicity of ST concern over occupational hazards associated with this chemical led to considerable interest to study of this agent on experimental animals. We found that ST induced dose-dependent elevations of ALT, AST and alkaline phophatase in rat liver. The effect of ST on experimental animals was reported by several investigators (7, 15, 22, 23). Hirasawa et al. (2007) reported that serum AST and ALT activities were significantly increased in rats treated with ST (22). Elevation of ALT and AST was noted in workers exposed to ST (24, 25).
Dose-related histopathological alterations were noted in rat liver treated with ST. we observed damage mainly in centrilobular area in rat liver. Similarly, short-term inhalation of mice to ST caused necrosis of centrilobular hepatocytes (26).
The mechanism by which ST produced toxicity is not completely understood. The initial step in the pathway leading to ST toxicity is generally assumed to be the biotransformation of ST to a reactive intermediate, possibly Styrene Oxide (SO) by cytochrome p450 (15). The presence of cytochrome p450 in the liver as well as kidney in various animal species has been described by many investigators (15, 27, 28).
The kidneys play a major role in the elimination of xenobiotics from the bloodstream. Nephrotoxicity is one of the most common adverse effects of toxic chemicals. A large body of evidence indicated that ST caused nephrotoxicity (10, 11, 29). An increased albumin excretion was noted in workers exposed to ST (10, 11). We observed that BUN and CR increased in a dose-dependent manner in ST-treated rats when compared with vehicle-treated animals. These results suggest an impairment of renal functional parameters due to ST exposure. Tubular injury in kidney of rat treated with ST was reported as evidenced by increasing of beta 2-microglobulinuria (30). Significant urinary excretion of gamma-glutamyltranspeptidase and proteins were noted in ST-treated rats (31). Our findings along with others suggested that kidney is susceptible for ST-induced toxicity. We observed that ST produced damage mainly in proximal convoluted tubular cells.
Since kidneys usually have low drug-metabolizing enzyme activities, chemically induced nephrotoxicity has been assumed to be produced by toxic intermediate (s) generated in the liver and transported to the kidney. As ST is eliminated via the kidney, another possibility for ST caused renal damage is that translocation of ST metabolites from the liver to the kidney via general circulation produced kidney injury. However, the generation of metabolites in kidney may at least in part be responsible for kidney toxicity.
Vitamin C is an antioxidant in cells, which has relatively high rate constant of its reaction with free radicals. It has been found that ST reduced level of Vit C and enhanced ST toxicity. Administration of Vit C protected rat against ST-induced lung injury (31, 32).
Our results indicated that ST induced injury in rat liver and kidney. Pretreatment of animals with Vit C markedly decreased ST hepatotoxicity and nephrotoxicity. These findings suggested that Vit C protected liver and kidney cells against ST toxicity and support the view that these organs have ability to metabolize ST and induced oxidative stress. On the basis of these results, we conclude that Vit C may prevent the occurrence of ST-induced adverse effects in humans.
Acknowledgements
References
-
1.
Lorimer WV, Lilis R, Nicholson WJ, Anderson H, Fischbein A, Daum S, et al. Clinical studies of styrene workers: initial findings. Environ Health Perspect. 1976;17:171-81. [PubMed ID: 1026403].
-
2.
Helal SF, Elshafy WS. Health hazards among workers in plastic industry. Toxicol Ind Health. 2013;29(9):812-9. [PubMed ID: 22609858]. https://doi.org/10.1177/0748233712442728.
-
3.
Gagnaire F, Langlais C. Relative ototoxicity of 21 aromatic solvents. Arch Toxicol. 2005;79(6):346-54. [PubMed ID: 15660228]. https://doi.org/10.1007/s00204-004-0636-2.
-
4.
Coccini T, Fenoglio C, Nano R, De Piceis Polver P, Moscato G, Manzo L. Styrene-induced alterations in the respiratory tract of rats treated by inhalation or intraperitoneally. J Toxicol Environ Health. 1997;52(1):63-77. [PubMed ID: 9269323]. https://doi.org/10.1080/00984109708984053.
-
5.
Gamer AO, Leibold E, Deckardt K, Kittel B, Kaufmann W, Tennekes HA, et al. The effects of styrene on lung cells in female mice and rats. Food Chem Toxicol. 2004;42(10):1655-67. [PubMed ID: 15304312]. https://doi.org/10.1016/j.fct.2004.06.002.
-
6.
Cruzan G, Cushman JR, Andrews LS, Granville GC, Johnson KA, Bevan C, et al. Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks. J Appl Toxicol. 2001;21(3):185-98. [PubMed ID: 11404830].
-
7.
Hartman JH, Boysen G, Miller GP. CYP2E1 metabolism of styrene involves allostery. Drug Metab Dispos. 2012;40(10):1976-83. [PubMed ID: 22807108]. https://doi.org/10.1124/dmd.112.046698.
-
8.
Kolstad HA, Ebbehoj N, Bonde JP, Lynge E, Albin M. [Health effects following occupational styrene exposure in the reinforced plastics industry]. Ugeskr Laeger. 2012;174(5):267-70. [PubMed ID: 22293073].
-
9.
Cave M, Falkner KC, Henry L, Costello B, Gregory B, McClain CJ. Serum cytokeratin 18 and cytokine elevations suggest a high prevalence of occupational liver disease in highly exposed elastomer/polymer workers. J Occup Environ Med. 2011;53(10):1128-33. [PubMed ID: 21915069]. https://doi.org/10.1097/JOM.0b013e31822cfd68.
-
10.
Voss JU, Roller M, Brinkmann E, Mangelsdorf I. Nephrotoxicity of organic solvents: biomarkers for early detection. Int Arch Occup Environ Health. 2005;78(6):475-85. [PubMed ID: 15895243]. https://doi.org/10.1007/s00420-005-0611-0.
-
11.
Verplanke AJ, Herber RF. Effects on the kidney of occupational exposure to styrene. Int Arch Occup Environ Health. 1998;71(1):47-52. [PubMed ID: 9523249].
-
12.
Polakova M, Krajcovicova Z, Melus V, Stefkovicova M, Sulcova M. Study of urinary concentrations of mandelic acid in employees exposed to styrene. Cent Eur J Public Health. 2012;20(3):226-32. [PubMed ID: 23285526].
-
13.
Cosnier F, Nunge H, Cossec B, Gate L. Simultaneous determination of aromatic acid metabolites of styrene and styrene-oxide in rat urine by gas chromatography-flame ionization detection. J Anal Toxicol. 2012;36(5):312-8. [PubMed ID: 22492963]. https://doi.org/10.1093/jat/bks015.
-
14.
Wang CJ, Shao H, Shang M, Zhang W. [Association between CYP2B6, CYP2D6, GSTP1 genetic polymorphisms and urinary styrene metabolites in professional workers]. Zhonghua lao dong wei sheng zhi ye bing za zhi= Zhonghua laodong weisheng zhiyebing zazhi= Chinese journal of industrial hygiene and occupational diseases. 2009;27(10):589-92.
-
15.
Carlson GP. Modification of the metabolism and toxicity of styrene and styrene oxide in hepatic cytochrome P450 reductase deficient mice and CYP2F2 deficient mice. Toxicology. 2012;294(2-3):104-8. [PubMed ID: 22386858]. https://doi.org/10.1016/j.tox.2012.02.006.
-
16.
Yuan W, Jin H, Chung JK, Zheng J. Evidence for cellular protein covalent binding derived from styrene metabolite. Chem Biol Interact. 2010;186(3):323-30. [PubMed ID: 20470765]. https://doi.org/10.1016/j.cbi.2010.05.004.
-
17.
Carlson GP. Depletion by styrene of glutathione in plasma and bronchioalveolar lavage fluid of non-Swiss albino (NSA) mice. J Toxicol Environ Health A. 2010;73(11):766-72. [PubMed ID: 20391119]. https://doi.org/10.1080/15287391003689143.
-
18.
Meszka-Jordan A, Mahlapuu R, Soomets U, Carlson GP. Oxidative stress due to (R)-styrene oxide exposure and the role of antioxidants in non-Swiss albino (NSA) mice. J Toxicol Environ Health A. 2009;72(10):642-50. [PubMed ID: 19308849]. https://doi.org/10.1080/15287390902769436.
-
19.
Hattiwale SH, Saha S, Yendigeri SM, Jargar JG, Dhundasi SA, Das KK. Protective effect of L-ascorbic acid on nickel induced pulmonary nitrosative stress in male albino rats. Biometals. 2013;26(2):329-36. [PubMed ID: 23463385]. https://doi.org/10.1007/s10534-013-9617-3.
-
20.
Casani S, Gomez-Pastor R, Matallana E, Paricio N. Antioxidant compound supplementation prevents oxidative damage in a Drosophila model of Parkinson's disease. Free Radic Biol Med. 2013;61:151-60. [PubMed ID: 23548634]. https://doi.org/10.1016/j.freeradbiomed.2013.03.021.
-
21.
Stojiljkovic N, Stoiljkovic M, Randjelovic P, Veljkovic S, Mihailovic D. Cytoprotective effect of vitamin C against gentamicin-induced acute kidney injury in rats. Exp Toxicol Pathol. 2012;64(1-2):69-74. [PubMed ID: 20619622]. https://doi.org/10.1016/j.etp.2010.06.008.
-
22.
Hirasawa F, Kawagoe M, Wang JS, Arany S, Zhou XP, Kumagai A, et al. Gadolinium chloride suppresses styrene-induced cytochrome P450s expression in rat liver. Biomed Res. 2007;28(6):323-30. [PubMed ID: 18202523].
-
23.
Carlson GP. Hepatotoxicity and pneumotoxicity of styrene and its metabolites in glutathione S-transferase-deficient mice. Drug Chem Toxicol. 2011;34(4):440-4. [PubMed ID: 21749217]. https://doi.org/10.3109/01480545.2011.562899.
-
24.
Brodkin CA, Moon JD, Camp J, Echeverria D, Redlich CA, Willson RA, et al. Serum hepatic biochemical activity in two populations of workers exposed to styrene. Occup Environ Med. 2001;58(2):95-102. [PubMed ID: 11160987].
-
25.
Kurppa K, Husman K. Car painters' exposure to a mixture of organic solvents. Serum activities of liver enzymes. Scand J Work Environ Health. 1982;8(2):137-40. [PubMed ID: 6127809].
-
26.
Mahler JF, Price HJ, O'Connor RW, Wilson RF, Eldridge SR, Moorman MP, et al. Characterization of hepatocellular resistance and susceptibility to styrene toxicity in B6C3F1 mice. Toxicol Sci. 1999;48(1):123-33. [PubMed ID: 10330692].
-
27.
Naud J, Michaud J, Beauchemin S, Hebert MJ, Roger M, Lefrancois S, et al. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats. Drug Metab Dispos. 2011;39(8):1363-9. [PubMed ID: 21525170]. https://doi.org/10.1124/dmd.111.039115.
-
28.
Liu S, Yao Y, Lu S, Aldous K, Ding X, Mei C, et al. The role of renal proximal tubule P450 enzymes in chloroform-induced nephrotoxicity: utility of renal specific P450 reductase knockout mouse models. Toxicol Appl Pharmacol. 2013;272(1):230-7. [PubMed ID: 23732084]. https://doi.org/10.1016/j.taap.2013.05.022.
-
29.
Chakrabarti SK, Tuchweber B. Effects of various pretreatments on the acute nephrotoxic potential of styrene in Fischer-344 rats. Toxicology. 1987;46(3):343-56. [PubMed ID: 3672539].
-
30.
Bernard AM, de Russis R, Normand JC, Lauwerys RR. Evaluation of the subacute nephrotoxicity of cyclohexane and other industrial solvents in the female Sprague-Dawley rat. Toxicol Lett. 1989;45(2-3):271-80. [PubMed ID: 2645690].
-
31.
Petrova S, Mikhailova A, Donchev N. [The effect of elevated amounts of ascorbic acid on the status of the vitamin and lung disorders in guinea pigs inhaling styrene]. Probl Khig. 1992;17:137-45. [PubMed ID: 1364534].
-
32.
Ahmadizadeh M, Pol T, Boazar M. Effect of Vitamin C on Styrene Induced Respiratory Toxicity. International Journal of Occupational Hygiene. 2011;3(2):76-80.